TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
3.310
-0.220 (-6.23%)
Mar 31, 2025, 3:41 PM EDT - Market open
TuHURA Biosciences Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for TuHURA Biosciences stock have an average target of 12, with a low estimate of 11 and a high estimate of 13. The average target predicts an increase of 262.54% from the current stock price of 3.31.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TuHURA Biosciences stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '25 | Mar '25 |
---|---|---|
Strong Buy | 1 | 2 |
Buy | 0 | 0 |
Hold | 0 | 0 |
Sell | 0 | 0 |
Strong Sell | 0 | 0 |
Total | 1 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +292.75% | Mar 3, 2025 |
Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +232.33% | Dec 19, 2024 |
Financial Forecast
Revenue This Year
10.75M
Revenue Next Year
34.52M
from 10.75M
Increased by 221.29%
EPS This Year
-0.47
from -0.43
EPS Next Year
-0.54
from -0.47
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | n/a | n/a | 22.1M | |||
Avg | n/a | n/a | 10.7M | |||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | -0.48 | -0.44 | -0.30 | |
Avg | -0.47 | -0.54 | -0.48 | |
Low | -0.45 | -0.72 | -0.64 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | - | - | - | |
Avg | - | - | - | |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.